Theratechnologies to Participate in Virtual Fireside Chat With Canaccord Genuity on May 20, 2021
On May 18, 2021, Theratechnologies (NASDAQ: THTX, TSX: TH) announced that CEO Paul Levesque will participate in a virtual fireside chat hosted by Edward Nash at Canaccord Genuity on May 20, 2021, at 2:00 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
On May 18, 2021, Theratechnologies (NASDAQ: THTX, TSX: TH) announced that CEO Paul Levesque will participate in a virtual fireside chat hosted by Edward Nash at Canaccord Genuity on May 20, 2021, at 2:00 p.m. ET. The event will be accessible via a live webcast on the company’s website, providing insights into its innovative therapies aimed at addressing unmet medical needs. The company emphasizes its commitment to developing and commercializing biopharmaceutical solutions.
Details
News Market Reaction – THTX
The recorded move for THTX in the trading session of this news was +0.27%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MONTREAL, May 18, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer will participate in a virtual fireside chat hosted by Edward Nash at Canaccord Genuity on Thursday, May 20, 2021 at 2:00 p.m. ET.
The live webcast will be available at https://www.webcaster4.com/Webcast/Page/2332/40747. The live and archived webcast link will also be available in the ‘News’ section of the Company’s website.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.
For media inquiries:
Denis Boucher
Vice-President, Communications and Corporate Affairs
514-336-7800
For investor inquiries:
Leah Gibson
Senior Director, Investor Relations
ir@theratech.com
617-356-1009
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.